Pages that link to "Q35811065"
Jump to navigation
Jump to search
The following pages link to Metals in our minds: therapeutic implications for neurodegenerative disorders (Q35811065):
Displaying 50 items.
- Plant metal chaperones: a novel perspective in dementia therapy (Q22248017) (← links)
- Human brain myelination and amyloid beta deposition in Alzheimer's disease (Q22252428) (← links)
- Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (Q24289511) (← links)
- Why nutraceuticals do not prevent or treat Alzheimer's disease (Q24793469) (← links)
- Bench-to-bedside translation of magnetic nanoparticles (Q26850547) (← links)
- Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (Q28388335) (← links)
- In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms (Q28389093) (← links)
- Magnetic nanoparticles for theragnostics (Q28389421) (← links)
- Molecular mechanisms of necroptosis: an ordered cellular explosion (Q29616004) (← links)
- The role of repulsive guidance molecules in the embryonic and adult vertebrate central nervous system. (Q31057708) (← links)
- Genes involved in the balance between neuronal survival and death during inflammation (Q33279528) (← links)
- Positron emission tomography for measurement of copper fluxes in live organisms (Q33610789) (← links)
- Effect of metals on kinetic pathways of amyloid-β aggregation (Q33649803) (← links)
- Zinc enhances ethanol modulation of the alpha1 glycine receptor (Q33830483) (← links)
- Lipoic acid - biological activity and therapeutic potential (Q34029023) (← links)
- The correlation of hippocampal T2-mapping with neuropsychology test in patients with Alzheimer's disease (Q35010262) (← links)
- Role of metal dyshomeostasis in Alzheimer's disease (Q35051952) (← links)
- Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals (Q35222298) (← links)
- Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder (Q35366778) (← links)
- Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review. (Q35561700) (← links)
- In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis. (Q35647740) (← links)
- Let Food Be Thy Medicine: Diet, Nutrition, and Biomarkers' Risk of Alzheimer's Disease (Q35836847) (← links)
- Regional dissection and determination of loosely bound and non-heme iron in the developing mouse brain (Q35962705) (← links)
- The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health (Q35986569) (← links)
- Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases (Q36649059) (← links)
- Therapeutic approaches for prion and Alzheimer's diseases (Q36872884) (← links)
- Antiinfective agents affecting cognition: a review (Q37071320) (← links)
- Promotion of cellular NAD( ) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer's disease. (Q37181486) (← links)
- Magnetic nanosystem for cancer therapy using oncocalyxone a, an antitomour secondary metabolite isolated from a Brazilian plant. (Q37225130) (← links)
- Pharmacotherapeutic targets in Alzheimer's disease (Q37295067) (← links)
- Targeting the progression of Parkinson's disease. (Q37299619) (← links)
- Alpha-lipoic acid supplementation and diabetes (Q37329377) (← links)
- Chronic Inflammatory Disorders and Their Redox Control: From Molecular Mechanisms to Therapeutic Opportunities (Q37851523) (← links)
- Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity (Q38074340) (← links)
- Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases (Q38244092) (← links)
- Is early-life iron exposure critical in neurodegeneration? (Q38534920) (← links)
- Emerging translational research on magnetic nanoparticles for regenerative medicine (Q38617021) (← links)
- Inhibition of amyloid oligomerization into different supramolecular architectures by small molecules: mechanistic insights and design rules (Q38686092) (← links)
- Brain Iron Metabolism Dysfunction in Parkinson's Disease. (Q38796693) (← links)
- Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. (Q39763280) (← links)
- Quiescence induced by iron challenge protects neuroblastoma cells from oxidative stress. (Q40262264) (← links)
- Rat adipose-derived mesenchymal stem cells aging reduction by zinc sulfate under extremely low frequency electromagnetic field exposure is associated with increased telomerase reverse transcriptase gene expression (Q41107111) (← links)
- Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal (Q41553884) (← links)
- Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid {beta} peptide (Q45271567) (← links)
- Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications (Q45305061) (← links)
- Effects of 85 dB noise exposure on macro and trace element levels in plasma and brain areas of rats. (Q45344212) (← links)
- Lack of glutathione peroxidase-1 exacerbates Abeta-mediated neurotoxicity in cortical neurons (Q46776548) (← links)
- Dysregulation of hypoxia-inducible factor by presenilin/γ-secretase loss-of-function mutations. (Q48186706) (← links)
- Redox silencing of copper in metal-linked neurodegenerative disorders: reaction of Zn7metallothionein-3 with Cu2 ions. (Q48227158) (← links)
- Metal swap between Zn7-metallothionein-3 and amyloid-beta-Cu protects against amyloid-beta toxicity. (Q50335544) (← links)